The high mortality rate in cancer such as oral squamous cell carcinoma is commonly attributed to the diffi culties in detecting the disease at an early treatable stage. In this study, we exploited the ability of gold nanoparticles to undergo coupled surface plasmon resonance and set up strong electric fi elds when closely-spaced to improve the molecular contrast signal in refl ectance-based imaging and also to enhance the Raman signal of bioanalytes in cancer. Colloidal gold nanoparticles were synthesized and conjugated to anti-epidermal growth factor receptor (EGFR) for imaging. A self-assembled surface enhanced Raman scattering (SERS)-active gold nanoparticle monolayer fi lm was also developed as a biosensing surface using a simple drop-dry approach. We have shown that gold nanoparticles could elicit an optical contrast to discriminate between cancerous and normal cells and their conjugation with antibodies allowed them to map the expression of relevant biomarkers for molecular imaging under confocal refl ectance microscopy. We have also shown that the SERS spectra of saliva from the closely-packed gold nanoparticles fi lms was differentiable between those acquired from normal individuals and oral cancer patients, thus showing promise of a simple SERS-based saliva assay for early diagnosis of oral cancer.
Introduction
Oral squamous cell carcinoma is the sixth most common cancer for both sexes worldwide. The 5-year survival rate of the disea0se is currently about 50%. Oral cancer is often diagnosed only after it has advanced to an untreatable stage (Spafford et al 2001; Zheng et al 2002) where the cancer cells have become aggressive and immune to therapeutic drugs. Detecting oral cancer at its earliest is thus vital for improving the survival rate of this disease. Current clinical diagnosis of most epithelial cancers, including oral cancer, typically involves performing invasive needle biopsies followed by histological examination on the excised tissue. The procedure may present psychological trauma and risk of infection to patients. Furthermore, biopsy is usually performed only under the condition that the lesions are spotted and appear abnormal (Lumerman et al 1995) . Yet, pre-cancerous lesions can appear innocuous or occur in hidden sites such as the crypts in the base of tongue, and can therefore easily go undetected even with white-light endoscopy (Spafford et al 2001) . Furthermore, conventional histopathological diagnosis is based on morphological and structural changes at the cellular or tissue level, which may not be obvious for early-stage tumors (Wickline and Lanza 2000) . Taken together, it is clear that a diagnostic method for detecting early stage oral cancer is highly desired.
Recently, an increased amount of efforts has been made to develop less-invasive early diagnostic modalities for oral cancer, of which the in vivo high resolution imaging of oral epithelial tissues using novel optical systems and the chemical analysis of saliva (Chen et al 2002) hold great promises as valuable tools. However, these techniques are met with several limitations to their effective use as diagnostic tools. Although advanced optical systems for in vivo imaging such as optical coherence tomography (OCT) and confocal refl ectance endomicroscopy are designed to image cell and stromal morphology for non-invasive clinical diagnosis in real time, the contrast between neoplastic and normal tissues is often too low to be of any clinical value (Wickline and Lanza 2002) . Furthermore, these structural-based imaging techniques are unable to image the biomolecular changes associated with carcinogenesis in vivo (Koenig et al 2001) due to their inherent optical confi gurations, which can provide earlier and more accurate diagnosis for suspicious pre-cancerous lesions as compared to their structural and morphological changes.
Although these biomolecular changes can potentially be detected through non-invasive quantitative assessment of the chemical compositions of saliva (Chen et al 2002) using techniques such as enzyme-linked immunosorbent assay (ELISA), micro-satellite analysis and high performance liquid chromatography (HPLC), these highly specifi c techniques in molecular detection are usually labor-intensive procedures and requires long analysis time. Even as this can be overcome substantially using mass spectrometry (MS), which normally gives a shorter analysis time and higher sensitivity, a clinically reliable MS data for saliva specimens is unfortunately hard to come by because issues such as ion-suppression effect, non-universal ionization effi ciency, and machine-to-machine variations, have complicated MS analysis of such complex sample as saliva (Li et al 2001) . Furthermore, these techniques have yet to discover reliable and well-validated markers for oral cancer. Raman spectroscopy is another technique that has long been used to study cancer-related chemical changes in both cancerous tissues as well as bio-fl uids. For instance, Li et al has shown that the Raman spectra of sera collected from normal individuals and cancer patients are different in more than 80% of cases for various cancers (Li et al 2001) . However, the Raman signals from these biologic samples are usually weak and not sensitive enough to merit clinical value.
Gold nanoparticles have recently been investigated to address the limitations of these imaging and chemical-based diagnostic techniques based on their optical properties. These metallic nanoparticles exhibit unique optical response to light which allow them to resonantly scatter light when excited at their surface plasmon resonance frequency (Mulvaney 1996) . Furthermore, the scattering cross section per particle is increased when the gold nanoparticles aggregate to produce an even larger optical signal (Sokolov, Follen et al 2003) . This mode of enhanced scattering from coupled surface plasmon resonances of aggregated gold nanoparticles can be exploited to provide good optical contrast if the gold nanoparticles can be brought close together in cellular environment under the infl uence of biochemical processes associated with disease pathology. As such, gold nanoparticles show potential as optical probes for refl ectance-based optical imaging to address their limitation in providing contrast for early biomolecular signatures present in cells and tissue (Schultz et al 2000; Sokolov, Follen et al 2003; El-Sayed et al 2005) . Furthermore, when the gold nanoparticles are closely-packed to form a fi lm, they are also capable of undergoing plasmon resonance with the laser excitation wavelength to generate strong excitation fi elds on the fi lm surface and this can be used to improve the sensitivity of optical based Raman spectroscopy for the chemical analysis of diluted fl uid analytes such as saliva specimen applied on its surface.
Gold nanoparticles also possess other favorable physicochemical properties for use as optical probes for early diagnostics. They can be easily conjugated to antibodies or peptides through electrostatic charge interaction or coordinate bonding to probe for specifi c cellular biomarkers with high specifi city and affi nity (Geoghegan and Ackerman 1977) . When coupled with appropriate biomarkers, these gold nanoparticles bioconjugates may provide useful optical signal for molecular specifi c information to assist clinicians in diagnosis of pre-cancers. Gold nanoparticles are also generally biocompatible and benign in biological tissues and have been applied for clinical treatment of other disease conditions such as rheumatoid arthritis (Abrams and Murrer 1993) .
In this study, our objectives were to develop colloidal gold nanoparticles as well as a self-assembled monolayer of these nanoparticles and exploit their ability to undergo coupled surface plasmon resonance and set up strong electric fi elds when closely-spaced for cancer diagnosis using both an imaging and chemical approach. Under the imaging approach, we demonstrated the use of these nanoparticles as an optical contrast agent for improving the optical contrast of clinically relevant biomarkers in epithelial cancer cells under refl ectance-mode imaging in vitro. The epidermal growth factor receptor (EGFR) is one such clinically relevant cell surface receptor biomarker used in this study that is overexpressed in vast majority of epithelial cancer but not in normal cells (Eisbruch et al 1987; Shin et al 1994; Ke et al 1998; Nouri et al 2000) . Under the chemical approach, we demonstrated the use of gold nanoparticles in surface enhanced Ra-man scattering (SERS) to enhance the Raman spectroscopy signal for the analysis of cancer-related chemical changes in saliva. We developed a simple and cost-effective method for preparing highly sensitive SERS-based saliva assay based on SERS-active gold nanoparticle fi lms and used it to collect and analyze spectroscopically, the SERS from the samplefi lm interface to seek for spectral features indicative of oral cancer. The use of saliva as a diagnostic fl uid would offer a few advantages over previous sera-based counterparts in that saliva is easily accessible, painlessly acquired and presents lower risk of infection compared to serum.
Materials and methods

Synthesis and characterization of gold nanoparticles
Colloidal gold nanoparticles were synthesized by the reduction of 0.259 mM of hydrogen tetrachloroaurate (SigmaAldrich) by 34 mM of trisodium citrate (Sigma-Aldrich) at temperature of 90 °C (Hayat 1989) . The particle size was determined by transmission electron microscopy (TEM) (Jeol JEM-1010 100 kV) to show uniform spherical and monodisperse gold nanoparticles with an average diameter of 15 nm. Their UV-Vis extinction spectrum was characterized using a UV-Vis spectrophotometer (Shimadzu UV-2401 PC). The side-scatter spectrum of the gold nanoparticles was characterized using a USB2000 miniature fi ber optic spectrophotometer (Ocean Optics, Inc) by illuminating the colloidal sample and detecting the spectrum at 90° to the incident illumination. The concentration of the gold nanoparticles in the colloid was characterized against known gold hydrosol standards from British Biocell International Ltd (EMGC.15, particle concentration = 1.4 × 10 12 particles per ml) and was determined to be approximately 1.23 × 10 12 particles per ml. This colloid was stored at 4 °C when not used.
SERS substrate preparation and characterization
SuperFrost
®
Plus microscope glass slides (VWR Scientifi c) were rinsed thoroughly with 70% v/v aqueous solution of ethanol (Merck) for 1 minute. The slides were then rinsed four times to remove traces of ethanol with fresh distilled water (18 MΩ, obtained from Millipore Mili-Q water purifi cation system) each time. The slides were stored in water until needed. To fabricate a gold particle fi lm, a 150-μl droplet of gold nanoparticles was pipetted onto the surface of a cleaned slide. The slide was then dried in a dessicator for 24 h, followed by rinsing in distilled water, after which the slides were dried with a dust blower. All of the prepared gold colloid fi lms were kept in distilled water until needed.
Optical transmission measurements of the resultant gold colloid fi lms were performed using a Shimadzu UV-2401 PC monochromator system. A cleaned SuperFrost ® Plus microscope slide was used as the reference sample. Each slide bearing a gold fi lm was placed in the illumination light path and secured with blue-tack. The light beam was passing through the slide perpendicularly. Care was taken to ensure that the blue-tack was not in the light path. Atomic force microscopy (AFM) measurements were performed under ambient conditions using a Digital Instrument DI3000 Nanoscope III in tapping mode (247.9 KHz) with a typical resolution of about 5 to 15 nm, and a horizontal scanning rate of 1 Hz.
Conjugation of gold nanoparticles with anti-EGFR
The gold nanoparticles were conjugated to monoclonal anti-EGFR (Santa Cruz Biotechnology Inc.) as our selected cancer biomarker for imaging via established protocols for passive absorption of anti-EGFR on the surface of gold nanoparticles. Briefl y, the conjugation was performed by incubating the gold nanoparticles with anti-EGFR for about 10 mins at room temperature as according to a modifi ed procedure reported previously (Geoghegan and Ackerman 1977) . The successful conjugation of antibodies on gold nanoparticles was ascertained by addition of 10% common salt solution and observing any visible color change in the colloidal solution.
The presence of salt caused unconjugated gold nanoparticles to aggregate and result in a visible color change from red to purple or gray. After the 10 minutes of incubation time, the anti-EGFR conjugated gold nanoparticles were washed and resuspended in 1X PBS buffer (pH 7.4) containing 5% bovine serum albumin (BSA) (Sigma Aldrich, Inc) and stored at 4 °C. Spectrophotometry was performed using the same Shimadzu UV-2401 PC monochromator system to confi rm conjugation of anti-EGFR to gold nanoparticles. The gold nanoparticles were also conjugated to BSA, a non-cellular binding protein, as negative control probes using the same procedures as above.
Cellular imaging
Both the poorly-differentiated nasopharyngeal epithelium carcinoma CNE2 cell line and the normal human lung fi broblast (NHLF) cell line were used in this study. The CNE2 cells were grown in RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM glutamine, sodium pyruvate, non-essential amino acids and 100 unit/ml penicillin/streptomycin while the normal cells were grown in fi broblast growth medium (Cambrex Corp.). Both cell lines were grown and maintained at 37 o C in humidifi ed 5% CO 2 and 95% air atmosphere. Prior to imaging, both cell lines were trypsinized and fi xed in 2% paraformaldehyde before incubating them with the anti-EGFR conjugated gold nanoparticles for 2 h at 37 °C. The cells were also incubated with BSA conjugated gold nanoparticles as a negative control for the antibody binding. Following the incubation, the cells were rinsed thrice with PBS to wash away the excess and unbounded gold bioconjugates and were then placed on a microscope slide for imaging. Imaging was performed using a confocal microscopy (LSM510 Meta, Carl Zeiss) in the refl ectance mode with a 20X olympus objective under 633 nm excitation with a helium-neon laser.
Preparation of saliva samples
Saliva samples were collected from 5 normal healthy individuals and 5 oral-cancer patients following their informed consent. This study was reviewed and approved by the Ethics Committee of the National Cancer Centre Singapore. Each subject was asked to rinse their mouth thoroughly with water for 30 min to remove any food particles in their oral environment, before expelling saliva into a 15 ml plastic container (Nalgene, Eppendorf). About 1 ml of whole saliva was obtained each time. The specimen was then transferred into a 1.5 ml Eppendorf centrifuge tube and spun, using the Eppendorf Centrifuge 5415C, at 14,000 rpm for 5 min to remove small particulates and exfoliated cells. The supernatant was then extracted and stored in a new centrifuge tube at -20 °C until needed. Note that only samples with no sign of blood contamination are used for the experiment.
SERS measurements
The Raman experiments were carried out with a modifi ed micro-Raman system, in which an Olympus microscope with a color closed circuit television (CCTV) system was coupled to a Spex 1704 spectrometer that was equipped with a liquid nitrogen cooled CCD detector. In this modifi ed system, the coupling optics was arranged in a box that was linked to the modifi ed optical microscope by a mechanical arm and fi xed to the Spex spectrometer. The laser light at 632.8 nm was introduced from the back of the box, after passing through a plasma fi lter and was then directed into the modifi ed microscope via a notch fi lter. This notch fi lter acted as a refl ection mirror to the laser light, but to the signal returning from the sample, it was a very effective fi lter to the Rayleigh (laser) line. This fi lter prevented any backscattered laser from entering the spectrometer, and hence from interfering with the Raman signals to be collected, but allowed Raman signals to transmit with little attenuation. The returned signals then passed through a second notch fi lter which was used to further improve the Rayleigh rejection. The Raman signal was then focused onto the entrance slit of the Spex spectrometer by a coated singlet focusing lens of 50 mm focal length. The inclusion of the CCTV system allowed both the laser beam and white light to be viewed directly from the monitor. A biological specimen could also be viewed directly from the monitor. The objective lens used in this study was from Olympus with magnifi cation 10 × and NA 0.25. The closely-packed gold particle fi lm was fi rst coated with a drop (approximately 30 μl) of saliva. Immediately, a 633 nm laser was focused, via a 10 × NA 0.25 objective, onto the sample-fi lm interface. Laser intensity at sample is about 2 mW. Spectrum acquisition was then started immediately. The spectral resolution was 1 cm -1 and an integration time of 10 s was used for all Raman measurements.
Results
The extinction and side-scatter spectrum of the gold nanoparticles is shown in Figure 1 . The extinction spectrum ( Figure 1a) shows a sharp peak at 520 nm which corresponds to the surface plasmon resonance typical of gold nanoparticles of that size (Murillo et al 2002) . The side-scatter spectrum (Figure 1b) shows that the gold nanoparticles have the potential to scatter light strongly at around 600 nm. Since the light scattering of biological tissue in this wavelength range is small compared to the light scattering afforded by gold nanoparticles (Taroni et al 2003) , the presence of the gold nanoparticles in tissue may be distinguishable from the scattering intensity. Spectrophotometry was used to confi rm the conjugation of anti-EGFR to gold nanoparticles. The extinction spectrum of the gold nanoparticles both before and after conjugation with anti-EGFR was measured and is shown in Figure 2 . The UV-Visible extinction spectrum shows a characteristic red-shift (≈6 nm) of the peak of the surface plasmon resonance which is typical of protein binding on the surface of the gold nanoparticles. This indicates the successful conjugation of anti-EGFR on the gold nanoparticles. An additional indication of anti-EGFR binding to the surface of the nanoparticles is their stability in 10% common salt solution where the gold bioconjugates did not aggregate to result in a color change after the addition of salt solution. The reduction in the intensity of the peak after conjugation could be due to the loss in some gold nanoshells during the washing steps after conjugation.
The ability of gold nanoparticles to increase the optical scattering of cells when attached to their surface was investigated by labeling the cells with these nanoparticles and observing them under confocal refl ectance microscopy. Figure 3 shows the confocal refl ectance images of CNE2 cells before and after labeling with anti-EGFR conjugated gold nanoparticles, as well as CNE2 cells labeled with our control of BSA conjugated gold nanoparticles which are not known to exhibit high binding affi nity to the cells. A signifi cant increase in the refl ectance signal was observed in the cells labeled with the antibody conjugated gold nanoparticles compared to the other two controls, where the refl ectance signal seemed to be non-specifi c and at random and could barely be resolved from the dark background. The increase in refl ectance signal that arose from the bright scattering ring formed could be attributed to the localization of the gold nanoparticles on the cell membrane as it was not observed in the unlabeled cells.
In addition to increasing the optical scattering on cells, the anti-EGFR conjugated gold nanoparticles also exhibited specifi city in binding to cancer cells overexpressing EGFR compared to normal cells. The labeling of anti-EGFR gold nanoparticles on both CNE2 and NHLF cells under confocal refl ectance microscopy is shown on Figure 4 together with their corresponding autofl uorescence image. The autofl uorescence images of the two cell lines show similar autofluorescence level. However, the overexpression of transmembrane EGFR in CNE2 cells caused more anti-EGFR gold nanoparticles to be selectively localized around the cytoplasmic membrane of the CNE2 cell compared to the nominal EGFR expression in normal NHLF cells, resulting in signifi cantly higher refl ectance intensity. The refl ectance intensity of the CNE2 cells is about 30 times higher than that of the NHLF cells, suffi cient to elicit an optical contrast between them for discriminating the cancerous against noncancerous cells. As the regions of increased refl ectance due to the presence of gold nanoparticles correspond to regions of high EGFR expression, this strong refl ectance signal could provide a map of EGFR expression under confocal refl ectance microscopy.
One of the objectives of this study was also to develop a simple and cost effective method for preparing SERS-active substrates which exploits the surface plasmon resonance of gold nanoparticles to enhance the Raman signal of bioanalytes. In particular, we looked at the fabrication of arrays consisting of closely spaced but non-aggregated monodisperse nanoparticles, since it has been established by many previous studies that such an array could generate large SERS-activity (Katherine et al 1995) . The large enhancement is derived mainly from the crevices between two adjacent particles, in which trapped analyte molecules experience enhanced electromagnetic fi eld due to coupled surface plasmon resonance (Katherine et al 1995) . Unfortunately, current techniques for preparing closely-spaced particle arrays are either too labourintensive or too costly to scale up. As such, we have developed a simple alternative approach in which closely-packed arrays of metallic nanoparticle fi lms were fabricated using a simple drop-dry approach. Figure 5 shows a SuperFrost ® Plus microscope slide bearing three colloid fi lms deposited by drying three 150-μl drops of gold nanoparticles containing 1.4 × 10 12 particles per ml as delineated above. Each fi lm is about 10 to 12 mm in diameter. Further observations under a microscope revealed interesting deposition pattern (see Figure 5b ). Basically, three types of structures could be observed: a ring at the perimeter, a continuous layer (white arrow) and an unevenly coated region (dark arrow).
A B D C
A representative UV-Vis spectrum of the gold nanoparticles fi lm is shown in Figure 6 , along with that of the gold nanoparticles colloid for comparison. One can immediately notice a double-peak feature in the fi lm's spectrum (see curve A), which is an indication of a closely-packed but non-aggregated morphology, according to a previous computer simulation (Sanchez-Gil et al 2002). The fi rst resonance peak in curve A situated at about 520 nm can be attributed to the plasmon resonance in the individual gold nanoparticles. The second peak located at 633 nm is derived from the collective plasmon oscillation among the closely-packed particles (Katherine et al 1995) . Further analysis of the surface morphology was obtained from the AFM mapping of the uniformly coated regions. The result is shown in Figure 7 . Analysis of the height profi le revealed that the fi lm was generally monolayer thick, with a small percentage of the total area being two-to three-particles thick.
Saliva samples were collected from 5 normal healthy individuals and 5 oral-cancer patients. Typical SERS spectra for these samples are shown in Figure 8 . Tentative assignment of the major vibrational bands in the spectra based on existing knowledge is presented in Table 1 . One of the differences between these spectra is the occurrence of Raman peaks at 670, 1097, and 1627 cm -1 in the abnormal-saliva spectrum (see bottom spectrum).
Discussion
The results of our study have demonstrated the exploitation of surface plasmon resonance of gold nanoparticles in performing cancer diagnosis through an imaging and a chemical analysis approach. We have synthesized and characterized the optical properties of 15 nm gold nanoparticles. The gold nanoparticles were conjugated to monoclonal anti-EGFR via passive absorption of the antibodies onto its surface and allowed to interact with cancer cells. The 6 nm red-shift in the peak surface plasmon resonance of the gold nanoparticles after conjugation with the antibody is associated with alterations in the local refractive index and hence dielectric constant around the surface of the gold nanoparticles particles due to the presence of a layer of antibodies around its surface. The change in dielectric constant affects the light scattering properties of gold nanoparticles according to the Mie theory (Bohren and Huffman 1983) . This red-shift is typical of protein binding on the surface of the gold nanoparticles and serves as an indication of the presence of the antibodies on the surface of the gold nanoparticles.
The results of our in vitro experiments with the CNE2 cells have demonstrated that the anti-EGFR gold nanoparticles could serve as a potential optical contrast agent to increase the detection visibility of cells under refl ectancebased imaging systems. The anti-EGFR were able to target and bind to the extracellular domain of EGFR on the cellular membrane even after conjugation to the gold nanoparticles. This means that the anti-EGFR still retains its antigen binding sites and activity after conjugation. The localization of the anti-EGFR gold nanoparticles forms highly refl ective beacons due to the strong resonant light scattering response of gold nanoparticles on the cell surface to the excitation light. This resonant scattering condition is further enhanced when the gold nanoparticles cluster close together on the cell membrane as they attach to their receptor and their surface plasmon interacts with each other. This result in bright refl ectance rings being formed around the cytoplasmic membrane and their optical refl ectance properties being increased signifi cantly under confocal refl ectance microscopy. In contrast, the strong refl ectance signal from the bright scattering rings was not observed in our control labeling with a non-binding BSA conjugated gold nanoparticles as the BSA were unable to target and bind to the cells and were therefore removed during the washing steps after the incubation.
Furthermore, our results have also demonstrated the possibility of exploiting the strong optical response of gold nanoparticles to transduce the molecular signals into observable optical signals and generate molecular contrast to image the expression of EGFR in cancer cells. The gold labeling pattern arising from the increased in refl ectance was able to provide a map of EGFR expression under confocal refl ectance microscopy. However, as the nucleus and other organelles in the cells are also generally refl ective (as depicted in Figure 4) , we do note that the signal-tonoise ratio achieved using such refl ective probe to image biomarker expression is generally lower than that achieved with fl uorescent probes. Nonetheless, the refl ectance signal from the gold nanoparticles probe should provide suffi ciently high contrast against intrinsic refl ectance signal in cells and tissue to map the biomarker expression under certain imaging application where the use of fl uorescence regime is not possible such as in OCT.
As EGFR is differentially expressed in the two cell lines used in this study, we made use of this differential expression of EGFR to regulate the amount of gold nanoparticles attached to the cells and thus elicit an optical contrast to "illuminate" the cancer cells over normal cells. This form of discrimination for a possible early cancer detection strategy is based solely on their molecular changes in biomarker expression rather than consequential phenotypic changes. The differences in refl ectance intensity could potentially be detected by promising clinical optical modalities such as OCT or confocal endomicrosope working in the refl ectance mode. In practice, the EGFR expression is detected at all stages of carcinogenesis, from normal- Normalized UV-Vis spectrum of a gold nanoparticles fi lm obtained by drying a suspension droplet with an initial particle concentration of 1.4 × 10 12 particles per ml (spectrum A) and the 15 nm colloidal gold nanoparticles (spectrum B).
early hyperplasia, dysplasia to invasive carcinoma (Kannan et al 1994; Shintani et al 1996) and it is elevated during the progression from hyperplasia to dysplasia and increases during progression from dysplasia to invasive carcinoma (Shin et al 1994) , thus giving a spectrum of expression levels with disease progression. As the refl ectance signal depends on the level of EGFR expression, its intensity may further provide indications of the progression of diseases at the molecular level. However, we also observed heterogeneous labeling with the anti-EGFR gold nanoparticles on CNE2 cells (Figure 3c and 4d) . This heterogeneity of protein expression in cell lines is common and has been described previously in the case of EGFR (Monaghan et al 1990) . Therefore, further studies need to be conducted to quantitatively relate the refl ectance signal from the gold nanoparticles attachment to the EGFR expression level in well-calibrated cell lines.
Although our in vitro results on cell lines seem promising, the use of gold nanoparticles in the same manner in vivo would warrant attention to the challenges in the way these nanoparticles could potentially elicit any body response and subsequently be eliminated from the body system with minimal side effects after their diagnostic use. Previous studies by other groups have shown that these gold nanoparticles tend to be taken up by the cells through endocytosis as fast as 1 h into the incubation with gold nanoparticles (Connor et al 2005) . In this case, the anti-EGFR binding to cell surface EGFR could potentially provide a receptor-mediated endocytosis route for the gold nanoparticles. Connor and colleagues examined a series of gold nanoparticles for cellular uptake and acute cytotoxicity in human leukemia cells and found that despite being taken up into the cells, spherical gold nanoparticles with a variety of surface modifi ers were not inherently toxic to human cells (Connor et al 2005) . Mukherjee et al have also shown that gold nanoparticles have no effect on gene expression or other global transcriptional pattern of human umbilical vein endothelial cells (HUVEC) (Mukherjee et al 2006) .
Although tests on other forms of body response in terms of cellular adhesion effects, local biological effects or other systemic and remote effects have not been performed in this study, previous literatures have shown that colloidal gold nanoparticles is an inert material that can be injected to living animals without major complications. The small size of these particles enables them to extravasate out of the microcirculation easily and diffuse through the interstitial compartments of tissue effi ciently. Without proper surface functionalization, most of the circulating nanoparticles will be trapped by reticuloendothelial system in liver, kidney, spleen and lungs and may remain there and in other tissue for a long time without interfering with metabolism of cells, although a small amount of gold nanoparticles may be secreted to the bile or urine (Eghtedari et al 2003) . Whilst metal poisoning is often associated with renal and hepatic toxicities, Mukherjee and colleagues have determined the effect of gold nanoparticles administration on liver and renal function on mice and found that there were no signifi cant differences between serum levels of creatinine, blood urea nitrogen, bilirubin alkaline phosphatase, alanine aminotransferase, and aspartate aminotransferase between gold nanoparticles treated and untreated control animals after 7 days of administration, thus concluding minimal effect of gold nanoparticles in renal and hepatic functioning (Mukherjee et al 2005) . Despite the fact that gold nanoparticles have been injected to many patients in the past to treat rheumatoid arthritis or to study the function of reticuloendothelial system based on the past three decades of literature, there are only a few, if any, reports on complications of intravenous gold injection (Gumpel 1974) .
Apart from enhancing the molecular contrast of cancer biomarkers under refl ectance-mode imaging, gold nanoparticles can also be closely packed to form a fi lm substrate to enhance the Raman signal of fl uid analytes. Figure 5 illustrates the typical structures of a gold particle fi lm fabricated using our deposition method. The detailed mechanism behind the formation of different regions in the deposited gold nanoparticle fi lms is currently being studied. Nevertheless, we stress that the different types of colloid regions are readily discernible under the microscope, and it is easy to identify and avoid the non-uniform colloid layers during a SERS measurement. Measurements have also showed that uniform Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles fi lms sized between 10 to 25 mm 2 can easily be reproduced using our current fabrication technique. A large colloid layer certainly has the advantage of ease of identifi cation and localization under the microscope. Figure 7 shows the typical AFM image of a uniformly coated region in the fi lms. As observed from the fi gure, it is diffi cult to ascertain whether these islands are actually consisting of closely-spaced gold nanoparticles or large aggregates due to the fact that the gold nanoparticles are too small to be resolved by the AFM tip. However, it is possible to "artificially" enhance the spatial resolution by digitally processing the image using a band-pass fi lter as described previously (Micheletto et al 1995) . From the processed image, the separation between two closest particle centers was estimated to be about 17 nm ± 15 %, which is comparable to the diameter of the individual particles. This result together with the doublepeak feature seen in the UV-Vis spectrum in Figure 6 leads us to believe that the particles are closely-packed but physically separated. Thus, assuming a particle radius of 7.5 nm, the particle-to-particle separation of 17 nm can be translated to an interparticle distance of about 2 nm, which is close to the thickness of the adsorbed ion layer (0.5-1 nm) on the particle surface (Giersig and Mulvaney 1993) , which in this case is the chloride ion. Note that in no case did we observe any interfering signal from this adsorbed ion layer. The stability of the particle fi lms was tested by immersing in a 10 % salt solution for 2 weeks. No re-suspension of particles was observed. There was also no re-suspension when saliva was applied on it. Such a good stability of the fi lm is attributable to the strong electrostatic attraction between the negatively-charged particles and the underlying positivelycharged SuperFrost ® Plus surface. We stress that our fi lms were assembled solely by the convection-induced particle fl ows in the wetting fi lm near the contact line of the drying droplet and not by the spontaneous electrostatic adsorption of particles on the solid surface as in the case of electrostatic self-assembly (Sastry 2002) . This was confi rmed by immersing a SuperFrost ® Plus glass slide in a colloidal solution of gold nanoparticles for 2 days. No particle attachment was observed. Furthermore, no stable colloid fi lm can be formed if the gold suspension drop is dried on a normal microsope glass slide, which lacks the electrostatic layers. Films formed on these slides were either partially or completely removed upon rinsing with distilled water.
Typical SERS saliva spectra are shown in Figure 8 . Three Raman peaks occurred at 670, 1079, and 1627 cm -1 are characteristic of saliva specimens collected from cancer patients. Of these bands, special note must be given to that situated at 1627 cm -1 , which were observed for 3 of the 5 saliva samples collected from the patients. This particular band was also observed in a previous Raman study of cancerous oral tissues (Ulas 1999) . As to whether there is any correlation in the Raman signals at 1627 cm -1 between the saliva spectra and those derived from the tissues is not known at the moment. Certainly, a comparison of SERS saliva spectra and the Raman spectra derived from matched oral tissues should provide an answer. This is currently being carried out in our lab. We are also unable to evaluate the applicability of using the saliva spectrum for cancer staging at this stage, owing to insuffi cient samples. More samples are needed. The inconsistency of SERS has also been noted in this study. The signal reproducibility of our fi lms is checked using Crystal Violet solution as test sample and found to be about 11% (data not shown). From further patient samples, we observe a sensitivity of the current technique in the range of around 70% ie,70% of the "abnormal" saliva shows abnormal peaks. However, none of the normal samples show these indicative peaks. We are currently working to develop a better SERS substrate consisting of periodic metallic nanostructures as opposed to the randomly-distributed nanoparticles fi lm employed in the current study. This should improve signal reproducibility, thereby rendering quantitative analysis of the absolute signal intensity possible. However, the results of this study show the potential of these simple gold nanoparticles fi lm for routine clinical diagnosis of oral cancer.
Conclusion
As cancer-associated biomarkers precede phenotypic manifestations of disease, there is a growing research interest in clinical molecular diagnostics for early cancer detection. Combining advances in biomedical optics and nanotechnology offers the opportunity to signifi cantly impact future strategies towards the detection and diagnosis cancer. This study demonstrates the potential of antibody conjugated gold nanoparticles to target and illuminate cancer cells under a refl ectance-based optical imaging system. In particular, we have shown that gold nanoparticles can provide an optical contrast to discriminate between cancerous and normal cells and their conjugation with antibodies also allows them to map the expression of relevant biomarkers for molecular imaging. Such molecular imaging has the potential to base disease detection on early molecular abnormalities before diseases become obvious with traditional imaging techniques. In addition, we have also demonstrated the use of SERS-active gold nanoparticle fi lms fabricated using a simple drop-dry approach in the chemical analysis of saliva. SERS spectra of saliva were obtained and shown to be differentiable between those acquired from normal individuals and oral cancer patients, thus showing promise of a simple SERS-based saliva assay for early diagnosis of oral cancer. All these may be translated to improved patient care by facilitating earlier cancer detection and phenotyping of tumors at a stage before debilitating or irreversible symptoms appear.
